Peter Rehling

Peter Rehling is a Professor at the University Medical Center Göttingen, currently serving as Acting Director of the Department of Developmental Biochemistry (since 2018) and Director of the Department of Cellular Biochemistry (since 2007). He holds key roles in multiple institutions, including Vice Dean of Sciences at the University Medical Center Göttingen (since 2017) and Speaker of SFB 1190 "Compartmental Gates and Contact Sites in Cells" (since 2016).

• Study: Biology and Chemistry at Ruhr University Bochum (1987–1993)
• Diploma: Plant Physiology, Ruhr University Bochum (with distinction, 1993)
• PhD: Physiological Chemistry, Ruhr University Bochum (summa cum laude, 1996)
• Habilitation: Biochemistry and Molecular Biology, University of Freiburg (2003)

His research focuses on mitochondrial biology, including:

• Mechanisms of mitochondrial protein import and signal transduction
• Assembly of oxidative phosphorylation systems and their role in disease
• Regulation of mitochondrial gene expression and translational coupling

Recent publications highlight his work on mitochondrial translocases (TIM22/TIM23), cardiolipin metabolism, and disease-associated protein complexes like MITRAC. Collaborative studies link mitochondrial dysfunction to cardiomyopathies and neuromuscular disorders.

Scientific honors include:

• ERC Advanced Investigator Grant (2013)
• Copernicus Award (DFG & FNP, 2016)
• Leopoldina (German National Academy of Science) membership (2018)
• Young Investigator Award (GBM & Schering Foundation, 2005)

He leads major research consortia, including the SFB860/SFB1190 structural biology projects and the International Max Planck Research School. His lab investigates mitochondrial biogenesis and its implications in rare diseases like Barth Syndrome.